Nasopharyngeal carcinoma (NPC) is a rare, aggressive form of head and neck cancer that originates in the nasopharynx, the ...

Dr. Reddy’s Laboratories on Thursday announced the launch of Toripalimab in India to treat adults with Nasopharyngeal ...

Dr. Reddy's Laboratories has announced the launch of Toripalimab in India. This drug is designed to treat adults suffering ...

Nasopharyngeal carcinoma (NPC) is a rare, aggressive form of head and neck cancer that originates in the nasopharynx, the ...

The drug is the only immuno-oncology drug approved by various regulatory authorities around the world for the treatment of ...

Dr. Reddys has launched Toripalimab, a novel immuno-oncology drug, in India for treating recurrent or metastatic nasopharyngeal carcinoma (RM-NPC). Toripalimab, already approved by USFDA and EMA, will ...

Dr Reddy's Laboratories has launched Toripalimab, a groundbreaking drug for treating recurrent or metastatic nasopharyngeal carcinoma (NPC) in India. The drug, marketed as Zytorvi, addresses an unmet ...

News on Telangana Today, Metastatic nasopharyngeal carcinoma (RM-NPC) latest news, Metastatic nasopharyngeal carcinoma (RM-NPC) news, | Telangana Today ...

Market witnessed selling pressure due to concerns over U.S. president Donald Trumps policies and renewed uncertainty in rate cut trajectory.

IST, the barometer index, the S&P BSE Sensex, tumbled 767.22 points or 0.95% to 79,469.24. The Nifty 50 index slipped 221.70 points or 0.90% to 24,056.20.

This study describes a decade's experience of the management of upper airway obstruction (UAO) in PRS patients with a nasopharyngeal airway (NPA). Methods This study was conducted by paediatric ...